Børn, som modtog 6 måneders behandling med Replagal, havde ingen forøgelse af hjertets størrelse, og Gb3- niveauerne i deres blod var reduceret.
Children who received 6-month treatment with Replagal had no increase in heart, and the levels of Gb3 in their blood was reduced.